Outcomes and clinical characteristics of the compassionate use of plitidepsin in COVID-19 patients with solid tumours, haematological malignancies or anti-CD20 antibody treatment

Jose Aguareles; Paula Villares Fernández; Carles Forné; Eva María Martí-Ballesteros; Virginia Pradillo Fernández; Gabriel Sotres-Fernandez; Adolfo de la Fuente-Burguera; Carolina Navarro-San Francisco; Luis Miguel Buzón-Martín; Teresa García-Delangue; Francesco Tommaso Aiello; Daniel Carnevali-Ruiz; Raquel Lloris; Xavier Erik Luepke-Estefan; José Antonio López-Martín; José María Jimeno; Ana García-Casas; Pablo Guisado-Vasco